Hypnosis for Transesophageal Echocardiography (I-SLEPT)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2010 by Assistance Publique - Hôpitaux de Paris.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT01095705
First received: March 29, 2010
Last updated: April 30, 2010
Last verified: March 2010

March 29, 2010
April 30, 2010
May 2010
September 2010   (final data collection date for primary outcome measure)
Level of patient comfort [ Time Frame: at Day 0 ] [ Designated as safety issue: No ]
Visual Analogic Scale
Same as current
Complete list of historical versions of study NCT01095705 on ClinicalTrials.gov Archive Site
  • Rate of procedure failure or non-diagnostic study [ Time Frame: at Day 0 ] [ Designated as safety issue: No ]
  • Duration of the procedure [ Time Frame: at Day 0 ] [ Designated as safety issue: No ]
  • Quality of the procedure as assessed by the operator [ Time Frame: at Day 0 ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Hypnosis for Transesophageal Echocardiography
Utility of Hypnosis for Transesophageal Echocardiography

The purpose of this study is to determine the additive value of hypnosis to improve patient comfort during transesophageal echocardiography (TEE).

TEE is a widely used diagnostic test in cardiovascular medicine. However, the test may be a source of discomfort to the patient. Patient intolerance of the echocardiography probe limits the duration of the procedure and therefore its diagnostic success. Current strategies to reduce patient discomfort involve global anesthesia, which carries its own side effects and risks of adverse events. Hypnosis may reduce patient discomfort without impairing alertness. The main goal of this study is to determine the additive value of hypnosis to improve patient comfort during TEE.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Discomfort
  • Procedure: Conventional procedure
    Local anaesthesia (Lidocaïne)
  • Procedure: Conventional procedure + Hypnosis
    Local anaesthesia (Lidocaïne) + Hypnosis (20 minutes)
  • Active Comparator: Conventional procedure
    Local anaesthesia (Lidocaïne)
    Intervention: Procedure: Conventional procedure
  • Experimental: Conventional procedure + Hypnosis
    Local anaesthesia (Lidocaïne) and Hypnosis
    Intervention: Procedure: Conventional procedure + Hypnosis
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
170
December 2010
September 2010   (final data collection date for primary outcome measure)

Inclusion criteria:

  • Patient with indication for a Transesophageal Echo (TEE)
  • Patient competent to provide written informed consent

Exclusion criteria:

  • Patient not subscribed to French Social Security System
  • Patient non-French speaking
  • Age < 18 years
  • Follow-up not possible
  • patient declared non competent to give informed consent for the study
  • History of severe personality disorder
  • Patient with a psychiatric treatment started 30 days before the exam
  • Patient pregnant or breast-feeding
  • Emergency TEE
  • Other indication for general anesthesia
Both
18 Years and older
No
Contact: François TOURNOUX, MD 01 49 95 82 25 francois.tournoux@lrb.aphp.fr
France
 
NCT01095705
P090802, 2009-A01156-51
No
VACHER Yannick, Department of clinical research and development
Assistance Publique - Hôpitaux de Paris
Not Provided
Principal Investigator: François TOURNOUX, MD Assistance Publique - Hôpitaux de Paris
Assistance Publique - Hôpitaux de Paris
March 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP